Atonu Rabbani1, G Caleb Alexander. 1. Center for Health and Social Sciences, The University of Chicago, 5841 S. Maryland, Chicago, IL, USA.
Abstract
OBJECTIVE: To examine the impact of family structure on pharmacologic stimulant use among children with attention-deficit/hyperactivity disorder (ADHD). DATA SOURCE: Nationally representative, population-based sample of the National Health Interview Survey from 1997 to 2003 linked with drug event files from the Medical Expenditure Panel Survey from 1998 to 2005. STUDY DESIGN: Stepwise multivariate logistic regression was used to examine the likelihood of stimulant use for each individual during 2 years of observation after adjustment for sociodemographic, health, and family characteristics. Stratified analyses were also conducted to examine whether family characteristics had different impacts within single-mother and dual-parent households. PRINCIPAL FINDINGS: Stimulant use varied based on children's sociodemographic and health characteristics. In multivariate analyses, associations between children's household structure, parental education, and stimulant use appeared to be mediated by children's access to care and health status. However, in full multivariate models, there remained a robust positive association between family size and stimulant use. CONCLUSIONS: These findings highlight the influence that nonclinical factors such as family size may have in mediating the use of pharmacologic therapies for children.
OBJECTIVE: To examine the impact of family structure on pharmacologic stimulant use among children with attention-deficit/hyperactivity disorder (ADHD). DATA SOURCE: Nationally representative, population-based sample of the National Health Interview Survey from 1997 to 2003 linked with drug event files from the Medical Expenditure Panel Survey from 1998 to 2005. STUDY DESIGN: Stepwise multivariate logistic regression was used to examine the likelihood of stimulant use for each individual during 2 years of observation after adjustment for sociodemographic, health, and family characteristics. Stratified analyses were also conducted to examine whether family characteristics had different impacts within single-mother and dual-parent households. PRINCIPAL FINDINGS: Stimulant use varied based on children's sociodemographic and health characteristics. In multivariate analyses, associations between children's household structure, parental education, and stimulant use appeared to be mediated by children's access to care and health status. However, in full multivariate models, there remained a robust positive association between family size and stimulant use. CONCLUSIONS: These findings highlight the influence that nonclinical factors such as family size may have in mediating the use of pharmacologic therapies for children.
Authors: Sami Timimi; Joanna Moncrieff; Jon Jureidini; Jonathan Leo; David Cohen; Charles Whitfield; Duncan Double; Jonathan Bindman; Henry Andrews; Eia Asen; Pat Bracken; Barry Duncan; Michaele Dunlap; Galves Albert; Michael Green; Tom Greening; Janice Hill; Rhodri Huws; Bertram Karon; Brian Kean; Michael McCubbin; Begum Miatra; Loren Mosher; Sue Parry; S DuBose Ravenel; Dominick Riccio; Richard Shulman; Jeanne Stolzer; Phil Thomas; Graham Vimpani; Al Wadsworth; Dave Walker; Norbert Wetzel; Rupert White Journal: Clin Child Fam Psychol Rev Date: 2004-03
Authors: T Spencer; J Biederman; T Wilens; M Harding; D O'Donnell; S Griffin Journal: J Am Acad Child Adolesc Psychiatry Date: 1996-04 Impact factor: 8.829
Authors: Kevin M Antshel; Teresa M Hargrave; Mihai Simonescu; Prashant Kaul; Kaitlin Hendricks; Stephen V Faraone Journal: BMC Med Date: 2011-06-10 Impact factor: 8.775